Acute reversible cardiomyopathy and thromboembolism after cisplatin and 5-fluorouracil chemotherapy: A case report

Angiology

Volumn 51, Issue 10, 2000, Pages 873-878

  Cheriparambil, Kuruvilla Mani ^a   Vasireddy, Hemalatha ^a   Kuruvilla, Anita ^a   Gambarin, Boris ^a   Makan, Majesh ^a   Saul, Barry I ^a  

^a NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ANTICOAGULATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CARDIOMYOPATHY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MOUTH CANCER; PALATE; PATHOPHYSIOLOGY; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; THROMBECTOMY; THROMBOEMBOLISM;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CARDIOMYOPATHIES; CISPLATIN; FLUOROURACIL; HEART DISEASES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PALATAL NEOPLASMS; THROMBOEMBOLISM;

EID: 0033767273     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970005101011     Document Type: Article

References (25)

1. Cardiac toxicity of 5-fluorouracil: A study on 1,083 patients
2. The syndrome of 5-fluorouracil cardiotoxicity: An elusive cardiopathy
3. 5-Fluorouracil cardiotoxicity: Left ventricular dysfunction and effect of coronary vasodilators
4. 5-Fluorouracil cardiotoxicity with left ventricular dysfunction under different dosing regimens
5. Acute myocardiotoxicity during 5-Fluorouracil therapy
6. 5-Fluorouracil-related toxic myocarditis: Case reports and pathological confirmation
7. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity
8. Major toxicity of cisplatin, fluorouracil and leukovorin following chemoradiotherapy in patients with nasopharyngeal carcinoma
9. Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C
10. Acute cardiac and renal failure after 5-FU and cisplatin treatment
11. Ischemic cardiopathy from cis-diamminedichloroplatinum (CDDP)
12. Acute coronary events following cisplatin-based chemotherapy
13. Severe vascular toxicity associated with cisplatin-based chemotherapy
14. Acute mesenteric ischemia associated with 5-FU, cisplatin, vincristine chemotherapy
15. Adverse cardiac effects during induction chemotherapy treatment with cisplatin and 5-fluorouracil
16. Cardiotoxicity during chemotherapy with 5-fluorouracil and cisplatin
17. Fluorouracil cardiotoxicity
18. Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil
19. Lethal cardiac toxicity after cisplatin and 5-fluorouracil chemotherapy
20. Intracardiac thrombi and systemic embolization
21. Thromboembolism in patients with decreased left ventricular function: Incidence, risk, treatment
22. Increased embolic risk in patients with left ventricular thrombi
23. Persistent intracardiac thrombi and systemic embolization despite anticoagulation therapy
24. The antineoplastic drug 5-fluorouracil produces echinocytosis and affects blood rheology
25. Changes in blood viscosity in patients treated with 5-fluorouracil - A link to cardiotoxicity?